Citeline podcast episode looks at the state of RNA therapeutics with Novotech’s Tom Hickey

July 17, 2025

Expert discussions with a focus on current market issues surrounding RNA therapeutics are all too rare, which is why we’re sharing this interview from Citeline.

Meredith Landry, Managing Editor of Citeline’s Custom Content, is joined by Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full-service clinical CRO dedicated to accelerating the development of advanced and novel therapeutics, for a timely discussion timely on the state of RNA therapeutics

Please enjoy this exchange, recorded at the annual BIO conference which took place in Boston in 2025.

Stay up to date with the latest news on RNA therapies